Avenzor for Pharmaceutical Industries S.A.

Avenzor for Pharmaceutical Industries S.A., established in 1991, operates within the Pharmaceuticals and Healthcare sectors. The company specializes in the production and marketing of pharmaceutical products, including anesthetics, antibacterial agents, and over-the-counter medications. Its primary objective is to provide effective pharmaceutical solutions to healthcare providers and patients. Avenzor's commitment to quality drives its market approach, ensuring its offerings meet stringent industry standards and patient needs.

With a workforce ranging from 1,000-5,000 employees, Avenzor demonstrates considerable operational scale. The company reports an annual revenue of $5.1M, underscoring its market penetration. Currently, Avenzor operates from a single primary location. Further insights into the organizational structure and personnel can be found by exploring Meet Avenzor for Pharmaceutical Industries S.A.'s team. This team is instrumental in developing and distributing its specialized pharmaceutical range.

Avenzor's market strategy is predominantly B2B, targeting healthcare professionals and institutions. The company actively participates in medical exhibitions to enhance its visibility and network within the healthcare community. Geographically, its operations are centered in Syria, with a strategic presence extending across Asia and the Middle East. This regional focus, combined with its founding in 1991, highlights Avenzor's established position and experience in the pharmaceutical industry.